Japan's Luca Science secures $30m Series B
Luca Science, a Japanese biotech start-up focused on dysfunctional and damaged tissues and organs, has raised a USD 30.3m Series B round led by life sciences specialists 4BIO Capital and DCI Partners.
It marks the first investment in Japan for 4BIO, which is based in the UK. 4BIO had an existing presence in the country, however, through its partnership with drug maker Kyowa Kirin, an LP in one its funds....
More on North Asia
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.